GlaxoSmithKline Pharmaceuticals
BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | Pharmaceuticals
 |
Half Yearly Results of GlaxoSmithKline Pharmaceuticals |
------------------- in Rs. Cr. ------------------- |
| Jun '07 | Dec '07 | Jun '08 | Dec '08 | Jun '09 | ||||||
| ||||||||||
|
||||||||||
| 6 mths | 6 mths | 6 mths | 6 mths | 6 mths | ||||||
|
||||||||||
| Sales Turnover | 811.80 | 758.50 | 837.83 | 847.73 | 924.94 | |||||
| Other Income | 58.41 | 31.43 | 60.00 | -31.74 | 18.00 | |||||
| Total Income | 870.21 | 789.93 | 897.83 | 815.99 | 942.94 | |||||
| Total Expenses | 544.45 | 488.35 | 534.51 | 553.09 | 589.13 | |||||
| Operating Profit | 267.35 | 270.15 | 303.32 | 294.64 | 335.81 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | 137.94 | -- | 128.21 | 10.53 | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 325.76 | 301.58 | 363.32 | 262.90 | 353.81 | |||||
| Interest | -- | -- | -- | -70.02 | -45.60 | |||||
| PBDT | 325.76 | 439.52 | 363.32 | 461.13 | 409.94 | |||||
| Depreciation | 7.38 | 8.78 | 7.61 | 8.73 | 7.63 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 318.38 | 430.74 | 355.71 | 452.40 | 402.31 | |||||
| Tax | 110.63 | 100.83 | 119.58 | 111.96 | 134.69 | |||||
| Net Profit | 207.75 | 329.91 | 236.13 | 340.44 | 267.62 | |||||
| Prior Year Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share(Rs) | 24.53 | 38.95 | 27.88 | 40.19 | 31.60 | |||||
| Book Value(Rs) | -- | -- | -- | -- | -- | |||||
| Equity | 84.70 | 84.70 | 84.70 | 84.70 | 84.70 | |||||
| Reserves | -- | 1,276.21 | -- | 1,456.39 | -- | |||||
| Face Value(Rs) | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore GlaxoSmithKline connections | ||||||||||
| ||||||||||
